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Abstract 
DO WOMEN TELL THEIR CONTRACEPTIVE CARE PROVIDERS ABOUT 
WHEN THEY HAVE THEIR ABORTIONS? 
Lisa An, Jessica Illuzzi, Clair Kaplan, and Nancy Stanwood. Section of Family 
Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences, 
Yale University, School of Medicine, New Haven, CT. 
 
We hypothesize that women underreport their abortions and contraceptive 
failures to their contraceptive care providers. If they do underreport, then their 
contraceptive care providers do not know about the contraceptive failures and 
cannot adjust their contraceptive practice accordingly. Without this adjustment, 
these women may receive poor contraceptive care. The political nature and 
stigma surrounding abortion have isolated it from the rest of women’s health care 
to the point that a gap in comprehensive contraceptive care exists. We studied 
the patient side of this gap by determining women’s rate of disclosure of abortion 
to their contraceptive care providers, who are separate from the abortion 
providers, reasons for nondisclosure, and what factors are associated with 
disclosure. 
A voluntary, anonymous, self-administered questionnaire of women 
seeking abortion services from Planned Parenthood of Southern New England 
was conducted to determine whether women have disclosed or plan to disclose 
their abortion to their contraceptive care providers. The questionnaire also 
collected information on contraceptive care provider characteristics, 
demographics, and reproductive health history. We conducted descriptive 
univariate and bivariate statistics as well as logistical regression modeling around 
disclosure of abortion. 
 iii 
Overall, 44% of women did not disclose their abortion to their 
contraceptive care provider. The most common reasons for nondisclosure of the 
abortion were “I don’t want them to know I’m having an abortion” (44%), followed 
by “I’m changing providers” (20%). Fourteen percent of women cited 
embarrassment about the pregnancy and fear of judgment as other reasons for 
nondisclosure. Women were 72% less likely to disclose to an 
obstetrical/gynecological (OB/GYN) provider (adjusted OR 0.28, 95% CI 0.10- 
0.75) and 90% less likely to disclose to a non-OB/GYN provider (adjusted OR 
0.10, 95% CI 0.02-0.42), compared to a Planned Parenthood contraceptive care 
provider.  
These results show that abortion stigma contributes to a broad shroud of 
secrecy since almost half of women do not disclose their abortion to their 
contraceptive care provider, who is separate from their abortion provider. Only 
provider type was associated with disclosure in a statistically significant way, 
while more intrinsic characteristics of the women, such as demographic or 
reproductive health history factors, were not. This suggests that abortion stigma 
is pervasive and can affect all types of women. Women’s health providers of any 
type have a unique responsibility to continue to destigmatize abortion and 
encourage use of the most effective methods of long acting reversible 
contraception, such as the intrauterine device and subdermal implant. In doing 
so, we may halt the unintended pregnancy epidemic in the United States.  
 iv 
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1 
Introduction 
 
Summary 
We hypothesize that women underreport their abortions and contraceptive 
failures to their contraceptive care providers. If women do underreport, then the 
contraceptive care providers do not know about the patients’ contraceptive 
failures and cannot adjust their contraceptive practice accordingly. Thus these 
providers are partly steering blind. The political nature and stigma surrounding 
abortion have isolated it from the rest of women’s health care to the point that a 
gap exists between the preventative care of contraception and the treatment for 
failed prevention, i.e., abortion care. In the current research, we have begun 
studying the patient side of this gap by examining issues around abortion 
disclosure to contraceptive care providers.  
 
Epidemic of Unintended Pregnancy  
The majority of the induced abortions in the United States occur in the 
setting of an unintended pregnancy. The overall unintended pregnancy rate in 
the United States has remained high over the past several years. In 2006, 6.7 
million pregnancies occurred, of which 49% were unintended, compared to 48% 
in 2001 (1). Low-income, cohabitating, and minority women aged 18-24 years 
with less than a high school education are at especially high risk for unintended 
pregnancies (2). Despite the fact that the unintended pregnancy rate remains 
high, the rate of abortion among those unintended pregnancies decreased from 
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47% in 2001 to 43% in 2006, while the unintended birth rate correspondingly 
increased (1-2). The decline in abortions over the past few years may be 
attributable to increased stigmatization for abortion and decreased access 
stemming from more stringent legal restrictions or lack of enough trained 
providers, or both.  
To understand the potential causes of unintended pregnancy, one must 
consider contraceptive use patterns. Three possible scenarios that lead to 
unintended pregnancy include contraceptive nonuse, inconsistent or incorrect 
contraceptive use, or contraceptive failure. In the United States, about 50% of 
women with unintended pregnancy were using contraception in the cycle when 
they conceived (2). Further, 60% of women who have abortions were using some 
method of contraception in the month they became pregnant (3). The most 
commonly used methods in the month of conception were the male condom 
(28%) and oral contraceptives (14%) (3). The majority of pill users (76%) and 
almost half of condom users (49%) reported using these methods inconsistently 
or incorrectly, and as such, inconsistent or incorrect method use was the most 
common reason these women became pregnant (3).  
Among contraceptive nonusers who had abortions, 33% of them thought 
that they had a low risk of becoming pregnant and 32% of them had concerns 
about using contraception, including fear of side effects or problems with use in 
the past (3). These findings show that women need accurate information about 
both the probability of conceiving without contraception as well as the safety 
profiles of the most effective methods of contraception. Since many women with 
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unintended pregnancy and abortion cite difficulties with contraceptives requiring 
daily use or use at every instance of sex, they would benefit more from 
“forgettable” contraceptive methods, specifically the intrauterine device or 
subdermal implant. These “forgettable” contraceptives, collectively called long-
acting reversible contracption (LARC), only require effort to have the device 
placed, while having the benefit of providing up to three to ten years of highly 
effective contraception thereafter. The findings also emphasize the important role 
of the contraceptive care provider to give information to women, while taking 
individual needs and past use into account, so that women are fully informed 
when choosing a method of contraception to prevent unintended pregnancy.  
 Other methods of contraception that are less effective with typical use 
compared to LARC include oral contraceptive pills, transdermal patch, and 
vaginal ring. Oral contraceptive pills contain either combined synthetic estrogen 
and progesterone or synthetic progesterone only. They inhibit ovulation and 
thicken cervical mucus to prevent pregnancy. The pill requires daily use, which 
can pose a challenge for some women. The transdermal patch and vaginal ring 
also contain combined synthetic estrogen and progesterone and have the same 
mechanism as the pill. The patch is applied to the skin and is changed weekly. 
The vaginal ring is inserted in the vagina and is changed monthly. The 
progesterone injection, called depot medroxyprogesterone acetate, lasts for three 
months and requires repeat appointments to receive additional injections every 
twelve weeks. The mechanism of the action for preventing pregnancy is inhibition 
of ovulation. Other less effective methods of contraception include barrier 
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methods, such as the male or female condom, diaphragm, or withdrawal (“pulling 
out”). These methods require use at every instance of sex to be effective. 
Condoms are important because they also provide protection against sexually 
transmitted infections. The least effective methods of contraception include 
fertility awareness methods, also called the rhythm method, and spermicide. 
Emergency contraception, or the “morning-after pill”, consists of synthetic 
progesterone. It prevents pregnancy by inhibiting ovulation, thickening cervical 
mucus to prevent entry of sperm, and thinning the uterine lining to prevent 
implantation of an embryo. It has no effect if the woman is already pregnant, or in 
other words if an embryo has already implanted.  
 
Abortion Provision in the United States 
The statistics about abortion providers in the United States highlight the 
disconnect in care between abortion and the rest of women’s health services. 
Abortions are performed in a variety of settings, such as hospitals and physician 
offices, but the majority (94%) occurs in the clinic setting (4). In 2008, 21% of all 
abortion providers, located at high volume abortion clinics, provided the majority 
of all abortions (70%) as compared to roughly the same number of providers in 
general physician offices who only performed 1% of all abortions (4). 
Unfortunately, the number of abortion providers has decreased significantly, by 
38%, between 1982 and 2005, but has remained stable in 2008 with 1,793 
providers (4).  
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The decrease in abortion providers underscores the fact that the current 
abortion provider pool is getting older and retiring, while the next generation of 
physicians is not stepping up in adequate numbers to replace them. Many of the 
current abortion providers are older physicians. They provide abortions because 
they saw firsthand the serious health consequences and deaths resulting from 
illegal and unsafe abortion in the United States prior to its legalization through the 
landmark Supreme Court case of Roe v. Wade in 1973. The newer generations 
of physicians and physicians-in-training have not seen firsthand the morbidity 
and mortality related to unsafe abortion, and thus may not be aware of the 
importance of continuing to learn about the medical and surgical techniques of 
abortion, to then in turn provide safe and legal abortions.  
The decrease in abortion providers translates into decreased access for 
abortion. In the United States, 87% of counties do not have an abortion provider, 
and 35% of women of reproductive age live in those counties (5). Also, 69% of 
metropolitan counties do not have access to an abortion provider, and 97% of 
rural counties have no abortion provider (6). Women are sometimes forced to 
travel long distances for abortion services. Non-hospital providers estimate that 
8% of their patients travel more than 100 miles and 19% travel 50-100 miles for 
abortion services (6). The geographic barriers to abortion care are substantial. 
 
Under-Reporting of Abortion by Women 
Even though the abortion rate may have decreased over the past few 
years, induced abortion overall remains a common procedure in the United 
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States. About one in three women in the United States between ages 15-44 
years have had at least one abortion in their lifetime (7). Despite the fact that 
abortion is a common and legal procedure, women only report about 45% of 
abortions performed in the United States (8-9). Another study surveying low-
income patients found 29% report the full number of abortions they have had 
(10). The percentage of women under-reporting also appears to be greater in 
non-white women than in white women (10-11). In terms of survey methods, self-
administered questionnaires produced higher levels of abortion reporting than 
face-to-face interviews (8). Thus women under-report the occurrence and 
frequency of abortion in epidemiologic studies. This under-reporting likely 
transfers into the physician office when women are asked to give an obstetrical 
history as part of routine gynecological care.  
 
Abortion Stigma  
Women under-report abortions because of the social stigma around 
abortion in the United States. Kumar et al. in 2009 describe that abortion 
transgresses three different feminine ideals of “female sexuality solely for 
procreation, the inevitability of motherhood, and instinctive nurturance of the 
vulnerable”. They also describe the idea of potential invisibility of abortion as 
opposed to continuous stigma of diagnosable disease, such as HIV or a physical 
deformity.  
Some qualitative studies examining abortion stigma and issues of 
disclosure more broadly have shown that there is an implicit rule of secrecy (12-
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14). The secrecy around abortion exists because women often fear that 
disclosure could lead to disapproval by others, loss of social or financial support, 
or they may assume that others are unwilling to listen. Other potential reasons for 
women’s nondisclosure of abortions include struggle in dealing with their own 
sense of morality, which may be in conflict with the abortion itself, or 
embarrassment about failing to prevent an unplanned pregnancy. Concealing the 
abortion often serves as a coping mechanism for the stigma to minimize any 
negative consequences (12, 14). While silence may initially benefit the woman by 
avoiding any conflict, it leads to a vicious cycle of repeated internalization of 
negative self-perceptions and thus reinforces the stigma (15). It also leads to 
feelings of isolation and deviancy despite the fact that abortion is quite common 
(16). One study showed that the more stigmatized women felt, the more they felt 
the need to keep their abortions a secret from friends and family (15). Almost 
70% of women disclosed their emotions about the abortion “not at all” or only “a 
little bit.” This led to higher rates of thought suppression and intrusive thoughts 
that were associated with post-abortion psychological distress (15). In addition to 
the potential for psychological distress, abortion secrecy can also lead to adverse 
health consequences. A recent case report highlights two cases where women 
felt the need to keep their abortion a secret, even in the setting of health 
complications (17). Their need for secrecy directly led them to delay seeking care 
for complications, worsening the morbidity of the complications (17). Overall the 
literature shows that abortion stigma plays a detrimental role in women’s lives 
and contributes to a broad shroud of secrecy.  
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Abortion Disclosure to Contraceptive Care Provider 
As an extension to this broad shroud of secrecy, we hypothesize that 
many women do not disclose their abortions to their contraceptive care providers. 
This may be during routine gynecologic history taking related to new 
contraceptive care, or more directly may be around the time of experiencing an 
unintended pregnancy and having an abortion. This latter scenario is our time of 
interest in this study. Because abortions leave no evidence of their occurrence, 
women have the ability to under-report without their contraceptive care providers 
knowing otherwise. Since many women do not report their abortions in 
epidemiological research, we hypothesize that women also under-report their 
contraceptive failures and abortions to their contraceptive care providers. If these 
providers are unaware of their patients’ abortions, they do not know their current 
contraceptive care has failed and cannot modify their patients’ contraceptive 
plans to better suit the patients’ needs. Ultimately, patients receive suboptimal 
family planning care. Imagine the difficulty of a general primary care provider 
trying to manage a diabetic patient’s medication regimen while unaware of the 
glycosylated hemoglobin level or of a recent admission for diabetic ketoacidosis.  
Though women often need both contraceptive care and abortion services, 
a disconnect exists in the way these services are delivered. The political climate 
around abortion in the United States has segregated abortion services from the 
rest of women’s health care so women are often shunted to independent abortion 
clinics. Some free-standing abortion clinics have high volume and subsequently 
insufficient time to address comprehensive contraception care. About 60% of 
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abortion centers provide only 6-15 minutes of contraceptive counseling and most 
commonly provide oral contraceptives, vaginal ring, or progesterone injection 
instead of more effective long-acting reversible methods (18). Only 32% of 
centers surveyed provide the intrauterine device or subdermal implant 
immediately postabortally, with comprehensive family planning centers being 
most likely to do so (18). The other side of the disconnect in comprehensive 
contraceptive services that has yet to be studied consists of clinicians who 
provide contraception and not abortion who may not be aware of their patients’ 
contraceptive failures.  
Our study addresses this disconnect from the patient perspective by 
determining what proportion of women, at the time of abortion, have told or are 
planning to tell their contraceptive care provider about the unintended pregnancy 
and abortion. In this research, the contraceptive care provider to whom we refer 
is separate from the abortion provider. We examined reasons for and factors 
associated with disclosure. This specific research question has not been studied 
directly, and may have significant implications for all practicing women’s health 
providers.  
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Statement of Purpose and Specific Aims 
 
 To determine what proportion of women, at the time of their abortion, have 
told or are planning to tell their contraceptive care provider about their 
pregnancy and abortion.  
 To determine why women do not tell their contraceptive care providers about 
their abortion.  
 To determine factors associated with abortion disclosure to contraceptive 
care providers.  
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Methods 
 
We conducted an anonymous, voluntary, self-administered, written survey 
of women seeking abortion services to determine whether they have disclosed or 
plan to disclose their abortion to their contraceptive care providers. The Yale 
Human Investigation Committee and the Planned Parenthood Federation of 
America Research Department approved the protocol. They deemed the study of 
minimal risk and waived written consent because a signed written consent form 
would be the only record linking the patient to the anonymous questionnaire. 
An introductory statement on the survey explained the purpose of the 
study and asked for voluntary participation while assuring anonymity. Decision to 
participate in the survey did not affect the subject’s medical care, and subjects 
had the option to decline to participate or to refrain from answering any particular 
question. Each subject was instructed to read the introductory statement, 
complete the survey, and then return the survey to a covered box provided in 
each clinic, whether or not she had chosen to complete it. The survey was 
available in English and Spanish. Contact information for study personnel was 
included on the cover sheet.  
Women of any age presenting for either surgical or medication abortion 
care were included. Adolescents were included without parental consent since 
the study was of minimal risk and because of their right to access reproductive 
health care services without parental consent in general. We excluded patients 
who: could not read or write in English or Spanish; did not have capacity to 
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provide consent; were not pregnant or seeking abortion services; or were 
prisoners or wards of the state.  
The survey instrument queried participants about basic demographics, 
reproductive health history, and methods of contraception used both during the 
month of conception and throughout their lifetime. The survey included questions 
on characteristics of the contraceptive care provider for subjects who had seen a 
provider for contraceptive care in the two years prior to completing the survey.  
Our main abortion disclosure outcome was elicited by the two following 
questions:  
 
“Does this [contraceptive care] provider know that you are having the 
Abortion?  
(1) Yes, and they referred me to an abortion provider,  
(2) Yes, but they did NOT refer me to an abortion provider,  
(3) No.  
If NO, do you think you will tell them about the Abortion?  
(1) Yes,  
(2) No,  
(3) No, but I will tell them I had a miscarriage,  
(4) Not sure.  
If you think you will NOT tell them about your Abortion, please CHECK 
ALL of the reasons you don’t want to tell them:  
(1) I’m embarrassed I got pregnant,  
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(2) I don’t want them to know I’m having an abortion,  
(3) I’m afraid they will be disappointed in me,  
(4) I’m afraid they will judge me,  
(5) I’m afraid other people in my life may find out about the pregnancy 
from their office,  
(6) They do not provide abortions,  
(7) I’m afraid my parents will find out,  
(8) Other reason:_______________________.”  
 
Similar wording was used to elicit information about disclosure of the pregnancy. 
See appendix for complete survey. The faculty mentor designed the first draft of 
the survey. The student revised the survey through multiple iterations, gathering 
and implementing feedback from the faculty mentor, Planned Parenthood’s 
research department and key leadership administrators, as well as from the 
Society of Family Planning Research Fund.  
Study participants were recruited from the following four sites in 
Connecticut that provide surgical abortion services of Planned Parenthood of 
Southern New England: 1) New Haven, 2) West Hartford, 3) Stamford, and 4) 
Norwich. These four clinics were chosen because of surgical abortion volumes, 
staff willingness to participate in the study, and clinic resources. Staff at the 
clinics offered the survey to all patients seeking medical or surgical abortions 
between mid-August 2012 to November 2012, and a covered box was available 
to collect the surveys after they were completed. Study subjects completed the 
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surveys in the waiting room prior to administration of any sedative or abortifacient 
medications. Study personnel were available by phone to answer any questions 
from study participants. The target was 150 completed surveys to use in the 
analysis, set as a convenience sample.  
Surveys received were classified into the following categories:  
 
1. Complete: surveys with complete disclosure questions and all or 
almost all of the rest completed 
2. Partially Complete: surveys that are mostly complete, except for 
missing some components of the key disclosure or contraceptive care 
provider questions 
3. Incomplete: surveys from subjects without a contraceptive care 
provider 
4. Missing: surveys with many missing variables 
 
Data entry and data coding were completed using Microsoft Excel 2008 
for Mac, Version 12.3.5.  Once initial data entry and data coding were complete, 
every survey entry was reviewed and checked for any errors.  
Next the coded data was imported into SAS for Windows, version 9.3. 
Surveys from the “Complete” category were used for all statistical analyses. The 
primary outcome variables examined were disclosure of abortion and disclosure 
of pregnancy to contraceptive care provider. We defined disclosure as past 
disclosure or intent to disclose and nondisclosure as intent not to disclose or 
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unsure about disclosure. All included subjects had contraceptive care providers 
who were distinct from the actual abortion providers, even if the contraceptive 
care provider was through Planned Parenthood. 
Descriptive univariate and bivariate statistics were calculated. The 
descriptive variables examined include: age, race/ethnicity, education, income, 
insurance, gravidity, parity, number of previous abortions, abortion type for 
current abortion (medical or surgical), and current gestational age. The bivariate 
statistics tabulated the demographics and reproductive health information by both 
disclosure of pregnancy and disclosure of abortion. Chi-square analyses or 
Fischer’s exact tests were calculated for the categorical variables, and Student’s 
t-test for the continuous variable of age.  
Descriptive univariate and bivariate statistics were calculated for 
contraceptive care provider type, and length of care with that provider. We 
elicited contraceptive care provider type information from participants by 
separately asking what type of office and what type of provider they saw for their 
contraception. We collapsed this information into a single variable for 
contraceptive care provider with the following options: Planned Parenthood, other 
obstetrical/gynecological (OB/GYN) clinician, and other non-OB/GYN clinician. 
Note that OB/GYN provider refers to physicians who specialize in obstetrics and 
gynecology as well as mid-level providers dedicated to women’s health, such as 
midwives or advanced nurse practitioners in a women’s health office. The 
OB/GYN provider category consists of private obstetrical/gynecological providers 
who are not part of the Planned Parenthood system, while the Planned 
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Parenthood category consists of contraceptive care providers who work at 
Planned Parenthood, distinct from the abortion providers. The non-OB/GYN 
category includes pediatricians, general medical practitioners, or any other 
provider type who does not specialize in women’s health. We also calculated chi-
square analyses for these variables. 
Descriptive statistics on methods of contraception used in respondents’ 
entire lives and in the month they became pregnant were calculated, as well as 
descriptive statistics on reasons for nondisclosure of pregnancy and abortion.  
Lastly logistical regression modeling was used to determine what factors 
are associated with disclosure of pregnancy and abortion. The model included 
the following variables: age, ethnicity/race, education, income, insurance type, 
gravidity, parity, previous abortions, current abortion type, current gestational 
age, and contraceptive care provider characteristics. The model was used to 
calculate unadjusted and adjusted odds ratios.  
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Results 
 
Study Population 
A total of 427 subjects participated in our study across the four sites. 
Sixty-six of those surveys were excluded because they contained too many 
missing variables. Of the remaining 361 surveys, 122 were excluded because 
those participants indicated that they did not have a contraceptive care provider 
and an additional 37 because they had incomplete disclosure or contraceptive 
care provider information (Fig. 1). The final study population consisted of 202 
surveys, of which 2% were completed in Spanish and 98% in English. The 
distribution of the final surveys roughly mirrors abortion volumes across the four 
clinic sites: 37% from New Haven, 31% from Stamford, 17% from West Hartford, 
and 15% from Norwich.  
 
Demographics of Study Population 
The mean and median ages of the participants were 26 years old and 25 
years old, respectively, and the range was between 16 and 44 years. The most 
common race or ethnicity was Caucasian/white at 39%, followed by African 
American/black at 35%, Hispanic at 14%, and Other/Mixed at 12%. The plurality 
of respondents had some college experience but without a degree at 33%, 
followed by high school or equivalent at 30%, greater than some college at 28%, 
and less than high school at 9%. In terms of income, almost half (46%) of the 
study population was poor, earning less than $20,000 per year, a quarter (25%) 
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made $20-40,000 per year, and 11% made over $40,000 per year. Mirroring the 
income levels, 56% of participants had Medicaid, 27% had private insurance, and 
17% were self-pay or uninsured. The demographics of the study population are 
presented in Table 1. 
Figure 1. Flow Chart from Initial Participants to Final Study Population 
427  
Initial  
Participants 
66  
Participants with Surveys with  
Many Missing Variables 
361  
Participants  
Remaining 
122 
Participants with No  
Contraceptive Care Provider 
239 
Participants  
Remaining 
202 
Participants in Final  
Study Population 
37 
Participants with Incomplete 
Disclosure Information 
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Table 1: Demographics and Reproductive Health Characteristics of Total Study 
Population 
 Total  
n (%) 
Age in years Mean 26 
Median 25 
Ethnicity/Race: 
  Hispanic 
 
28 (14.1) 
  African American/black 70 (35.4) 
  Caucasian/white 77 (38.9) 
  Other: Asian, Native American, Mixed Race, or Other 23 (11.6) 
Education: 
  Less Than High School 
 
19 (9.4) 
  High School or GED 61 (30.2) 
  Some College 66 (32.7) 
  Associate’s Degree or Above 56 (27.7) 
Annual Income: 
  Less than $20,000 
 
90 (46.4) 
  $20,000-$40,000 48 (24.7) 
  More than $40,000 21 (10.8) 
  Unsure 35 (18.0) 
Insurance for the Abortion: 
  Private 
 
53 (26.9) 
  Medicaid 110 (55.8) 
  None, Self-Pay 34 (17.3) 
Gravidity: 
  1 
 
39 (19.6) 
  2 47 (23.6) 
  3 36 (18.1) 
  4 or more 77 (38.7) 
Parity: 
  0 
 
75 (37.9) 
  1 64 (32.3) 
  2 44 (22.2) 
  3 or more 15 (7.6) 
Previous Abortions: 
  0 
 
84 (42.4) 
  1 63 (31.8) 
  2 30 (15.2) 
  3 or more 21 (10.6) 
Abortion Type Planned: 
  Surgical 
 
161 (81.3) 
  Medical 25 (12.6) 
  Unsure 12 (6.1) 
Gestational Age: 
  First Trimester 
 
183 (92.4) 
  Second Trimester 9 (4.6) 
  Unsure 6 (3.0) 
Note: Percentages may not add exactly to 100 due to rounding. A few of the variables presented above had 
minimal numbers of missing data; all had less than 8 missing. 
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Reproductive Health Characteristics of Study Population 
 The plurality of respondents, 39%, had been pregnant 4 or more times. 
For 20% of women, this was their first pregnancy, and for 24% this was their 
second pregnancy. However, the plurality of women (38%) had borne no 
children, a third had had one child, and 22% had had two children. For 42% of 
participants, this was their first abortion, 32% had one prior abortion, and 15% 
had two prior abortions. The majority of women (81%) planned to undergo 
surgical abortion, while 13% decided to have medication abortion. Over 90% of 
respondents were in the first trimester, and only 5% were in the second trimester. 
See Table 1 for more details. 
 
Methods of Contraception 
 Participants most commonly used the following methods of contraception 
in the month of they became pregnant: condoms (49%), withdrawal (29%), oral 
contraceptives (19%), and nothing (18%). Condoms were the most common 
method of contraception (87%) used in respondents’ entire lives, followed by oral 
contraceptives (74%), withdrawal (50%), depot medroxyprogesterone acetate 
(28%), and emergency contraception (23%). Overall, fewer than 10% of women 
had ever used the most effective methods, long-acting reversible contraceptives, 
such as the intrauterine device or subdermal implant. See Table 2 for more 
details.  
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Table 2: Most Commonly Used Methods of Contraception 
 
Note: Subjects were allowed to select multiple methods of contraception so the percentages sum to greater 
than 100. Three surveys had missing data for the methods of contraception used in the month of 
conception. Also, not all methods or combinations of methods are presented. Long-acting reversible 
contraception is defined as the intrauterine device or subdermal implant. 
 
Disclosure Rates 
 Overall, 58% of women already disclosed or plan to disclose their current 
pregnancies to their contraceptive care providers, while 42% did not plan to 
disclose or were unsure about disclosure. A similar percentage of respondents, 
56%, already disclosed or plan to disclose their abortion to their contraceptive 
care provider, and 44% did not plan to disclose or were unsure about disclosure 
(Table 3). The majority of women had concordant disclosure rates for both the 
pregnancy and abortion—54% already disclosed or planned to disclose both and 
 In the Month of 
Conception 
n (%) 
Ever Used 
n (%) 
Withdrawal: 
  Withdrawal Alone 
  Withdrawal with Condoms 
  Total Withdrawal 
 
16 (8.0) 
18 (9.0) 
57 (28.6) 
 
 
 
100 (49.5) 
Condoms: 
  Condoms Alone 
  Condoms with Withdrawal 
  Total Condoms 
 
53 (26.6) 
18 (9.0) 
97 (48.7) 
 
 
 
175 (86.6) 
Oral Contraceptives: 
  Total Oral Contraceptives 
 
38 (19.1) 
 
149 (73.8) 
Transdermal Patch: 
  Total Patch 
 
1 (0.5) 
 
38 (18.8) 
Vaginal Ring: 
  Total Vaginal Ring 
 
6 (3.0) 
 
39 (19.3) 
Depot Medroxyprogesterone Acetate (Depo): 
  Total Depo 
 
6 (3.0) 
 
56 (27.7) 
Long Acting Reversible Contraception (LARC): 
  Total LARC 
 
4 (2.0) 
 
18 (8.9) 
Emergency Contraception (EC): 
  Total EC 
 
13 (6.5) 
 
46 (22.8) 
Nothing, I thought I wouldn’t get pregnant: 
  Nothing Alone 
  Nothing Total 
 
27 (13.4) 
36 (18.1) 
 
7 (3.5) 
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40% did not plan to disclose or were unsure about disclosure of both. For this 
study, we define nondisclosure to include participants who are unsure about 
disclosure as well as those who do not plan to disclose. Similarly, we define 
disclosure to include participants who have already disclosed or plan to disclose. 
Note that disclosure to contraceptive care provider was examined, not disclosure 
to the abortion provider.  
 
Table 3: Statistics on Pregnancy and Abortion Disclosure 
 Disclosed  Did Not Disclose 
Already Told 
Provider 
n (row %) 
Plan to Tell 
Provider 
n (row %) 
Total 
n (total %) 
Will Not 
Disclose 
n (row %) 
Not Sure 
n (row %) 
Total 
n (total %) 
Pregnancy 90 (44) 28 (14) 118 (58) 46 (23) 38 (19) 84 (42) 
Abortion 72 (36) 40 (20) 112 (56) 49 (24) 41 (20) 90 (44) 
Note: Provider refers to contraceptive care provider. 
 Table 4 and 5 show comparisons of demographic and reproductive health 
information between those who have disclosed their pregnancy and abortion and 
those who have not disclosed. The chi-square, Fischer’s exact, and Student’s t-
tests did not show any significant differences between the participants who 
disclosed and who did not disclose; the p-values were all greater than 0.05. 
However, the contraceptive care provider type showed statistical significance (p-
value 0.009) when examining the differences in disclosure of pregnancy, and 
approached significance (p-value 0.092) when examining the differences in 
disclosure of abortion (Table 6 and 7).  
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Table 4: Demographics and Reproductive Health Characteristics of Study 
Population Based on Disclosure of Pregnancy 
 Those Who Have Not 
Disclosed to Provider  
n (row %)
 
Those Who Have 
Disclosed to Provider  
n (row %) 
P-Value 
Age in Years Mean: 26.0 Mean: 26.4 0.6517
 
Ethnicity/Race: 
  Hispanic 
 
12 (42.9) 
 
16 (57.1) 
0.883 
  African American/black 29 (41.4) 41 (58.6) 
  Caucasian/white 34 (44.2) 43 (55.8) 
  Other: Asian, Native American,  
     Mixed Race, or Other 
8 (34.8) 15 (65.2) 
Education: 
  Less Than High School 
 
6 (31.6) 
 
13 (68.4) 
0.735   High School or GED 24 (39.3) 37 (60.7) 
  Some College 29 (43.9) 37 (56.1) 
  Associate’s Degree or Above 25 (44.6) 31 (55.4) 
Income: 
  Less than $20,000 
 
38 (42.2) 
 
52 (57.8) 
0.931   $20,000-$40,000 19 (39.6) 29 (60.4) 
  More than $40,000 10 (47.6) 11 (52.4) 
  Unsure 14 (40.0) 21 (60.0) 
Insurance: 
  Private 
 
18 (34.0) 
 
35 (66.0) 
0.321 
  Medicaid 51 (46.4) 59 (53.6) 
  Self-Pay 14 (41.2) 20 (58.8) 
Gravidity: 
  1 
 
16 (41.0) 
 
23 (59.0) 
0.175   2 26 (55.3) 21 (44.7) 
  3 13 (36.1) 23 (63.9) 
  4 or more 28 (36.4) 49 (63.6) 
Parity: 
  0 
 
32 (42.7) 
 
43 (57.3) 
0.787   1 26 (40.6) 38 (59.4) 
  2 17 (38.6) 27 (61.4) 
  3 or more 8 (53.3) 7 (46.7) 
Previous Abortions: 
  0 
 
39 (46.4) 
 
45 (53.6) 
0.204   1 28 (44.4) 35 (55.6) 
  2 10 (33.3) 20 (66.7) 
  3 or more 5 (23.8) 16 (76.2) 
Abortion Type: 
  Surgical 
 
64 (39.8) 
 
97 (60.2) 
0.433 
  Medical 13 (52.0) 12 (48.0) 
  Unsure 6 (50.0) 6 (50.0) 
Gestational Age: 
  First Trimester 
 
76 (41.5) 
 
107 (58.5) 
0.699
 
  Second Trimester 5 (55.6) 4 (44.4) 
  Unsure 2 (33.3) 4 (66.7) 
Note: Chi-square analyses were conducted on each variable, except for age (Student’s t-test) and 
gestational age (Fischer’s exact).  
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Table 5: Demographics and Reproductive Health Characteristics of Study 
Population Based on Disclosure of Abortion 
 Those Who Have Not 
Disclosed to Provider 
n (row %)
 
Those Who Have 
Disclosed to Provider 
n (%) 
P-Value 
Age in Years Mean: 26.0 Mean: 26.4 0.6854
 
Ethnicity/Race: 
  Hispanic 
 
16 (57.1) 
 
12 (42.9) 
0.544 
  African American/black 30 (42.9) 40 (57.1) 
  Caucasian/white 34 (44.2) 43 (55.8) 
  Other: Asian, Native American,  
     Mixed Race, or Other 
9 (39.1) 14 (60.9) 
 
Education: 
  Less Than High School 
 
6 (31.6) 
 
13 (68.4) 
0.674   High School or GED 29 (47.5) 32 (52.5) 
  Some College 30 (45.5) 36 (54.5) 
  Associate’s Degree or Above 25 (44.6) 31 (55.4) 
Income: 
  Less than $20,000 
 
42 (46.7) 
 
48 (53.3) 
0.946   $20,000-$40,000 20 (41.7) 28 (58.3) 
  More than $40,000 10 (47.6) 11 (52.4) 
  Unsure 16 (45.7) 19 (54.3) 
Insurance: 
  Private 
 
17 (32.1) 
 
36 (67.9) 
0.093 
  Medicaid 55 (50.0) 55 (50.0) 
  Self-Pay 16 (47.1) 18 (52.9) 
Gravidity: 
  1 
 
15 (38.5) 
 
24 (61.5) 
0.135   2 28 (59.6) 19 (40.4) 
  3 15 (41.7) 21 (58.3) 
  4 or more 31 (40.3) 46 (59.7) 
Parity: 
  0 
 
33 (44.0) 
 
42 (56.0) 
0.867   1 29 (45.3) 35 (54.7) 
  2 18 (40.9) 26 (59.1) 
  3 or more 8 (53.3) 7 (46.7) 
Previous Abortions: 
  0 
 
40 (47.6) 
 
44 (52.4) 
0.496   1 30 (47.6) 33 (52.4) 
  2 11 (36.7) 19 (63.3) 
  3 or more 7 (33.3) 14 (66.7) 
Abortion Type: 
  Surgical 
 
70 (43.5) 
 
91 (56.5) 
0.713 
  Medical 13 (52.0) 12 (48.0) 
  Unsure 5 (41.7) 7 (58.3) 
Gestational Age: 
  First Trimester 
 
81 (44.3) 
 
102 (55.7) 
0.777 
  Second Trimester 5 (55.6) 4 (44.4) 
  Unsure 3 (50.0) 3 (50.0) 
Note: Chi-square analyses were conducted on each variable, except for age (Student’s t-test) and 
gestational age (Fischer’s exact).  
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Table 6: Contraceptive Care Provider Characteristics Based on Disclosure of 
Pregnancy 
 Those Who Have 
Not Disclosed the 
Pregnancy to 
Provider 
n (row %)
 
Those Who Have 
Disclosed the 
Pregnancy to 
Provider 
n (row %) 
P-Value Total 
n (total %) 
Provider Type: 
  Planned Parenthood 
 
10 (23.8) 
 
32 (76.2) 
0.009 
 
42 (20.8) 
  OB/GYN 61 (43.9) 78 (56.1) 139 (68.8) 
  Other: General Medical,   
     Pediatric, or Not Sure 
13 (61.9) 
 
8 (38.1) 21 (10.4) 
Length of Care: 
  Less than 6 months 
 
16 (44.4) 
 
20 (55.6) 
0.178 
 
36 (18.1) 
  6-12 months 15 (55.6)  12 (44.4) 27 (13.6) 
  1-2 years 19 (47.5) 21 (52.5)  40 (20.1) 
  More than 2 years 33 (34.4) 63 (65.6) 96 (48.2) 
Note: Row percentages may not add exactly to 100 due to rounding error. Provider refers to contraceptive 
care provider. OB/GYN provider is defined as physicians specializing in obstetrics and gynecology as well 
as mid-level providers dedicated to women’s health, outside of Planned Parenthood.  
 
Table 7: Contraceptive Care Provider Characteristics Based on Disclosure of 
Abortion 
 Those Who Have 
Not Disclosed the 
Abortion to 
Provider 
n (row %)
 
Those Who Have 
Disclosed the 
Abortion to 
Provider 
n (row %) 
P-Value Total 
n (total %) 
Provider Type: 
  Planned Parenthood 
 
13 (31.0) 
 
29 (69.1) 
0.092 
 
42 (20.8) 
  OB/GYN 65 (46.8) 74 (53.2) 139 (68.8) 
  Other: General Medical,   
    Pediatric, or Not Sure 
12 (57.1) 9 (42.9) 21 (10.4) 
Length of Care: 
  Less than 6 months 
 
17 (47.2) 
 
19 (52.8) 
0.090 
 
 
36 (18.1) 
  6-12 months 17 (63.0) 10 (37.0) 27 (13.6) 
  1-2 years 19 (47.5) 21 (52.5) 40 (20.1) 
  More than 2 years 35 (36.5) 61 (63.5) 96 (48.2) 
Note: Row percentages may not add exactly to 100 due to rounding error. Provider refers to contraceptive 
care provider. OB/GYN provider is defined as physicians specializing in obstetrics and gynecology as well 
as mid-level providers dedicated to women’s health, outside of Planned Parenthood.  
 
 
Reasons for Non-Disclosure of Pregnancy and Abortion 
 The most common reason for non-disclosure of the pregnancy and 
abortion was “I don’t want them to know I’m having an abortion” at 39% and 44%, 
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respectively. Surprisingly, the respondents chose “I’m switching providers” as the 
second most common reason for nondisclosure of pregnancy and abortion, at 
24% and 20%, respectively. Since this was a write-in response to “other reason”, 
the total number of women who have decided to switch providers is likely an 
underestimation. Based on what women wrote in their “other” responses, the 
main reasons for switching providers were related to relocation, insurance 
changes, or general dissatisfaction for the service they received. Lower 
percentages of women chose “They do not provide abortions”, “I’m embarrassed 
I got pregnant”, or “I’m afraid they will judge me” (Table 8 and 9). 
Table 8: Reasons for Non-Disclosure of Pregnancy 
Reason Total n (%) 
I’m embarrassed I got pregnant 14 (20.0) 
I don’t want them to know I’m having an abortion 27 (38.6) 
I’m afraid they will be disappointed in me 9 (12.9) 
I’m afraid they will judge me 11 (15.7) 
I’m afraid other people in my life may find out about 
the pregnancy from their office 
6 (8.6) 
They do not provide abortions 12 (17.1) 
I’m afraid my parents will find out 6 (8.6) 
I’m changing providers 17 (24.3) 
Other reason 10 (14.3) 
Note: The percentages sum to greater than 100 since subjects could select more than one response. The 
total includes subjects who do not plan to disclose and who are not sure about disclosure. Total number of 
respondents is 70.  
 
Table 9: Reasons for Non-Disclosure of Abortion 
Reason Total n (%) 
I’m embarrassed I got pregnant 10 (14.3) 
I don’t want them to know I’m having an abortion 31 (44.3) 
I’m afraid they will be disappointed in me 7 (10.0) 
I’m afraid they will judge me 10 (14.3) 
I’m afraid other people in my life may find out about 
the abortion from their office 
7 (10.0) 
They do not provide abortions 13 (18.6) 
I’m afraid my parents will find out 6 (8.6) 
I’m changing providers 14 (20.0) 
Other reason 13 (18.6) 
Note: The percentages sum to greater than 100 since subjects could select more than one response. The 
total includes subjects who do not plan to disclose and who are not sure about disclosure. Total number of 
respondents is 70.  
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Logistic Regression Modeling For Disclosure of Pregnancy 
 Logistic regression modeling was conducted for disclosure of pregnancy 
to determine factors associated with disclosure. The model converged with the 
inclusion of the following variables: age, ethnicity/race, education, income, 
insurance type, gravidity, parity, previous abortions, abortion type planned, 
current gestational age, contraceptive care provider type, and length of care with 
provider. Having an OB/GYN as a contraceptive care provider was associated 
with 76% lower likelihood to disclose the pregnancy to one’s provider compared 
to having a Planned Parenthood contraceptive care provider (adjusted OR 0.24; 
95% CI 0.08-0.70) (Table 10). In addition, the odds of disclosure of the 
pregnancy are even lower to a non-OB/GYN provider compared to a Planned 
Parenthood contraceptive care provider, (adjusted OR 0.05; 95% CI 0.01-0.26). 
Thus, the odds of women disclosing their abortion are 95% less likely with a non-
OB/GYN provider compared to a Planned Parenthood contraceptive care 
provider. Note that a Planned Parenthood contraceptive care provider is distinct 
from the abortion provider.  
Table 10: Logistic Regression Modeling for Disclosure of Pregnancy 
Factor Unadjusted Odds Ratio 
(95% Confidence Interval) 
Adjusted Odds Ratio  
(95% Confidence Interval) 
Age 1.01 (0.97-1.06) 1.02 (0.94-1.11) 
Ethnicity/Race: 
  Hispanic 
 
1.05 (0.44-2.53) 
 
0.68 (0.20-2.37) 
  African American 1.12 (0.58-2.15) 1.51 (0.57-3.98) 
  Caucasian Reference Reference 
  Other: Asian, Native American,  
     Mixed Race, or Other 
1.48 (0.56-3.91) 2.13 (0.59-7.73) 
Education: 
  Less Than High School 
 
1.41 (0.47-4.20) 
 
2.03 (0.43-9.59) 
  High School or GED Reference Reference 
  Some College 0.83 (0.41-1.68) 1.26 (0.49-3.30) 
  Associate’s Degree or Above 0.80 (0.39-1.68) 1.19 (0.37-3.78) 
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Annual Income: 
  Less than $20,000 
 
Reference 
 
Reference 
  $20,000-$40,000 1.12 (0.55-2.28) 0.80 (0.30-2.11) 
  More than $40,000 0.80 (0.31-2.09) 0.46 (0.10-2.20) 
  Unsure 1.10 (0.50-2.43) 1.26 (0.42-3.81) 
Insurance: 
  Private 
 
1.68 (0.85-3.32) 
 
4.74 (1.54-14.61)
* 
  Medicaid Reference Reference 
  Self-Pay 1.24 (0.57-2.69) 4.65 (1.36-15.95)
* 
Gravidity: 
  1 
 
Reference 
 
Reference 
  2 0.56 (0.24-1.33) 0.41 (0.09-1.10) 
  3 1.23 (0.48-3.13) 1.62 (0.15-17.29) 
  4 or more 1.22 (0.55-2.68) 3.32 (0.17-65.55) 
Parity: 
  0 
 
Reference 
 
Reference 
  1 1.09 (0.55-2.14) 0.69 (0.14-3.52) 
  2 1.18 (0.55-2.53) 0.23 (0.03-1.80) 
  3 or more 0.65 (0.21-1.98) 0.20 (0.02-2.53) 
Previous Abortions: 
  0 
 
Reference 
 
Reference 
  1 1.08 (0.56-2.09) 0.73 (0.21-2.48) 
  2 1.73 (0.73-4.15) 0.68 (0.10-4.72) 
  3 or more 2.77 (0.93-8.26) 0.82 (0.13-5.37) 
Abortion Type Planned: 
  Surgical 
 
Reference 
 
Reference 
  Medical 0.61 (0.26-1.42) 0.20 (0.06-0.65)
* 
  Unsure 0.66 (0.20-2.14) 0.24 (0.04-1.60) 
Gestational Age: 
  First Trimester 
 
Reference 
 
Reference 
  Second Trimester 0.57 (0.15-2.19) 1.16 (0.15-9.00) 
  Unsure 1.42 (0.25-7.95) 6.78 (0.39-117.12) 
Provider Type: 
  Planned Parenthood 
 
Reference 
 
Reference 
  OB/GYN 0.40 (0.18-0.87)
* 
0.24 (0.08-0.70)
* 
  Other: General Medical,  
     Pediatric, Not Sure 
0.19 (0.06-0.60)
* 
0.05 (0.01-0.26)
* 
Length of Care: 
  Less than 6 months 
 
Reference 
 
Reference 
  6-12 months 0.64 (0.23-1.75) 0.81 (0.21-3.10) 
  1-2 years 0.88 (0.36-2.18) 1.19 (0.33-4.33) 
  More than 2 years 1.53 (0.70-3.33) 2.66 (0.89-7.92) 
*
statistically significant finding (p-value < 0.05) 
Note: For the adjusted model, the odds ratios are calculated using 175 surveys since the statistical program 
deleted 27 surveys from the model due to missing data. 
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Logistic Regression Modeling For Disclosure of Abortion 
 Logistic regression modeling was conducted for disclosure of abortion to 
determine factors associated with disclosure. As with the model for disclosure of 
pregnancy, this model for abortion disclosure converged with the inclusion of the 
same variables: age, ethnicity/race, education, income, insurance type, gravidity, 
parity, previous abortions, abortion type planned, current gestational age, 
contraceptive care provider type, and length of care with provider. Similarly, 
women were 72% less likely to disclose the abortion to an OB/GYN contraceptive 
care provider (adjusted OR 0.28; 95% CI 0.10-0.75), compared to a Planned 
Parenthood contraceptive care provider as the reference (Table 11). In addition, 
the odds of disclosure of the abortion are even lower to a non-OB/GYN provider 
compared to Planned Parenthood, (adjusted OR 0.10; 95% CI 0.02-0.42). Thus, 
the odds of women disclosing their abortion are 90% less likely with a non-
OB/GYN provider compared to a Planned Parenthood contraceptive care 
provider. Again, the Planned Parenthood contraceptive care provider is distinct 
from the abortion provider. 
Table 11: Logistic Regression Modeling for Disclosure of Abortion 
Factor Unadjusted Odds Ratio 
(95% Confidence Interval) 
Adjusted Odds Ratio  
(95% Confidence Interval) 
Age 1.01 (0.96-1.06) 0.99 (0.91-1.08) 
Ethnicity/Race: 
  Hispanic 
 
0.59 (0.25-1.42) 
 
0.55 (0.17-1.82) 
  African American 1.05 (0.55-2.03) 1.48 (0.58-3.77) 
  Caucasian Reference  
  Other: Asian, Native American,  
     Mixed Race, or Other 
1.23 (0.48-3.18) 1.50 (0.44-5.12) 
Education: 
  Less Than High School 
 
1.96 (0.66-5.84) 
 
2.07 (0.47-9.17) 
  High School or GED Reference Reference 
  Some College 1.09 (0.54-2.19) 1.11 (0.45-2.74) 
  Associate’s Degree or Above 1.12 (0.54-2.33) 1.32 (0.43-4.02) 
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Annual Income: 
  Less than $20,000 
 
Reference 
 
Reference 
  $20,000-$40,000 1.23 (0.60-2.49) 0.87 (0.34-2.20) 
  More than $40,000 0.96 (0.37-2.49) 0.56 (0.13-2.42) 
  Unsure 1.04 (0.48-2.27) 1.27 (0.44-3.71) 
Insurance: 
  Private 
 
2.12 (1.07-4.21)
* 
 
4.31 (1.48-12.53)
* 
  Medicaid Reference Reference 
  Self-Pay 1.13 (0.52-2.43) 4.25 (1.28-14.09)
* 
Gravidity: 
  1 
 
Reference 
 
Reference 
  2 0.42 (0.18-1.01) 0.31 (0.07-1.40) 
  3 0.88 (0.35-2.21) 0.65 (0.07-5.99) 
  4 or more 0.93 (0.42-2.04) 1.07 (0.06-18.07) 
Parity: 
  0 
 
Reference 
 
Reference 
  1 0.95 (0.49-1.86) 1.35 (0.29-6.22) 
  2 1.14 (0.53-2.41) 0.60 (0.09-3.96) 
  3 or more 0.69 (0.23-2.09) 0.55 (0.05-6.20) 
Previous Abortions: 
  0 
 
Reference 
 
Reference 
  1 1.00 (0.52-1.92) 0.90 (0.28-2.90) 
  2 1.57 (0.67-3.70) 0.97 (0.16-5.10) 
  3 or more 1.82 (0.67-4.96) 0.72 (0.12-4.40) 
Abortion Type Planned: 
  Surgical 
 
Reference 
 
Reference 
  Medical 0.71 (0.31-1.65) 0.25 (0.08-0.81)
* 
  Unsure 1.08 (0.33-3.53) 0.34 (0.06-1.90) 
Gestational Age: 
  First Trimester 
 
Reference 
 
Reference 
  Second Trimester 0.64 (0.17-2.44) 1.15 (0.16-8.48) 
  Unsure 0.79 (0.16-4.04) 1.85 (0.15-23.18) 
Provider Type: 
  Planned Parenthood 
 
Reference 
 
Reference 
  OB/GYN 0.51 (0.25-1.06) 0.28 (0.10-0.75)
* 
  Other: General Medical,  
     Pediatric, Not Sure 
0.34 (0.11-0.99)
* 
0.10 (0.02-0.42)
* 
Length of Care: 
  Less than 6 months 
 
Reference 
 
Reference 
  6-12 months 0.53 (0.19-1.46) 0.72 (0.19-2.69) 
  1-2 years 0.99 (0.40-2.44) 1.64 (0.49-5.56) 
  More than 2 years 1.56 (0.72-3.39) 3.04 (1.07-8.65)
* 
*
statistically significant (p-value <0.05) 
Note: For the adjusted model, the odds ratios are calculated using 176 surveys since the statistical program 
deleted 26 surveys from the model due to missing data.  
 
The association of contraceptive care provider type to disclosure of abortion was 
similar to the results from the disclosure of pregnancy model.  
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In creating the adjusted model, the statistical program deleted 26 surveys 
due to missing variables. As such, some variables showed a new finding of 
statistical significance, such as insurance type, abortion type planned, or length 
of care with provider. However, the p-values for these variables from the chi-
square calculations with the bivariate statistics and in the unadjusted model were 
greater than 0.05. The exclusion of 26 surveys in the adjusted model likely 
skewed this result since this finding was not stable across all calculations. The 
rest of the odds ratios showed that the remainder of demographics and 
reproductive health variables had 95% confidence intervals that crossed the null 
value in both the unadjusted and adjusted models.  
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Discussion 
 
Interpretation of Disclosure Data 
Almost half of women in our study did not disclose their unintended 
pregnancy or their abortion to their contraceptive care providers. Disclosure was 
associated with provider type, with women being significantly more likely to 
disclose to their pre-established Planned Parenthood clinician who is distinct 
from the abortion provider than to a separate private OB/GYN clinician or non-
OB/GYN clinician. No other factors–including demographics, education, 
insurance status, and income–were consistently associated with disclosure in our 
analysis. 
The reasons for nondisclosure of abortion highlight that fear of stigma is 
common. Our findings echo other research showing that abortion stigma leads to 
secrecy of the abortion (12-16, 17). Surprisingly, almost a quarter of women 
surveyed who chose not to disclose their pregnancy or abortion felt the need to 
change providers. We are probably underestimating the total number of women 
who feel this way because this response was gleaned from written responses in 
the “other” category. This finding may indicate that many women are unhappy 
with care they received and may blame the provider in part for the unplanned 
pregnancy. Alternatively, they may fear judgment by these providers, and this 
may prompt their switch in providers. Other common reasons for nondisclosure 
were “I’m embarrassed I got pregnant” and “I’m afraid they [my provider] will 
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judge me”, further underscoring that women fear potential judgment and negative 
attitudes from their providers if they disclose. 
Women feel the most comfortable disclosing their pregnancy and abortion 
to a Planned Parenthood contraceptive care provider compared to a general 
OB/GYN provider or to other types of providers, such as a general practitioner or 
pediatrician. Note that we define OB/GYN provider as physicians or mid-level 
providers devoted to women’s health, such as midwives or advanced nurse 
practitioners, who practice outside of the Planned Parenthood setting. This 
finding suggests that women perceive Planned Parenthood to be less or non-
judgmental in regards to unplanned pregnancy and abortion when compared to 
other reproductive health care clinicians or non-OB/GYN clinicians. This is in line 
with the findings of Major and Gramzow that showed that women are less likely 
to disclose their abortion if they feel like they may be judged negatively (15). 
Planned Parenthood is known for supporting the full range of women’s 
reproductive health decisions, and our data mirrors women’s perception of this 
fact. Another possible interpretation is that the type of women who go to Planned 
Parenthood for their abortion and contraceptive care may already feel less 
stigmatized from abortion at baseline, and thus would be more likely to disclose.  
In addition, our finding from the logistical regression modeling that women 
with private insurance or women who self-pay were more likely to disclose than 
women with Medicaid is likely a spurious result. From the chi-square analyses of 
the bivariate statistics, this finding was not significant as the p-values were 
greater than 0.05. Only with the adjusted model did the odds ratios appear 
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significant with a confidence interval that did not cross one for both disclosure of 
pregnancy and abortion. Since a few of the surveys in our study population 
contained some missing variables, the statistical program removed those from 
the adjusted model. This likely skewed the results as our total sample size is 
small.  
It is interesting that all of the intrinsic characteristics we examined, such as 
race/ethnicity, age, income, education level, gravidity, or parity, were not 
associated with disclosure in any statistically significant way. Only the provider 
type showed any robust associations with disclosure of pregnancy and abortion. 
This suggests that abortion stigma is pervasive across all types of women. 
Women of any socioeconomic status, race/ethnicity, or age may feel the negative 
effects of abortion stigma that can lead to nondisclosure. 
 
Implications of Nondisclosure of Abortion 
Nondisclosure of abortion can harm women’s health if the desire for 
nondisclosure supersedes sound decision-making around potential health 
complications. Although the complication rate for abortion in the United States is 
extremely low, nondisclosure of abortion has the potential to exacerbate 
complications when they do occur. A recent case report published in Obstetrics 
and Gynecology describes unsafe consequences if women continue to keep their 
abortions a secret (17). One of the cases described a woman who had ruptured 
membranes after laminaria were placed that led to an infection. Even in the 
setting of threatened sepsis, she chose to keep silent in fear of facing any stigma 
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from others. She eventually was rushed to the hospital by ambulance after her 
condition deteriorated. This whole situation may have been averted if the woman 
did not feel so stigmatized for the abortion to the point that she would rather risk 
her own health than disclose the abortion. This example depicts the harms that 
may result from nondisclosure of abortion and how abortion stigma contributes to 
a harmful shroud of secrecy.  
 The case report example underscores the harmful effects of nondisclosure 
of one’s pregnancy and abortion to family members and friends. Imagine that 
even after the abortion, as the woman continues contraceptive care with her 
women’s health provider, she omits this valuable past medical history. The 
provider, unknowingly, would continue prescribing a suboptimal contraceptive 
regimen, such as oral contraceptives, instead of more effective methods. Typical 
use of oral contraceptives has a 9% failure rate, and its inconsistent use probably 
led to the unplanned pregnancy and the abortion in the first place, as the majority 
of cases do (3). A general physician or endocrinologist would agree that a similar 
situation with a diabetic patient who chooses to keep an admission to the 
intensive care unit for diabetic ketoacidosis a secret would be considered an 
obstacle to a basic standard of patient care. In addition, if the glycosylated 
hemoglobin remained elevated with metformin alone, why would the provider 
continue this regimen instead of starting insulin, which would provide more 
effective glycemic control? The bottom line is that secrecy about abortion can 
harm women’s health and contributes to the epidemic of unintended 
pregnancy.  
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A possible solution to the abortion stigma and nondisclosure dilemma lies 
in destigmatizing abortion, creating an environment where women feel safe to 
disclose, and supporting patients in a neutral, non-judgmental way. A qualitative 
study on abortion stigma described a theme of dissatisfaction with health 
professional attitudes and demeanors that the women perceived as “judgmental” 
(14). Another study piloted an intervention of introducing women who had had a 
recent abortion to a “culture of support” by providing validating messages and 
information about groups and services that support women in their reproductive 
decisions (19). The intervention consisted of a documentary screening about 
women’s experiences with abortion, a brochure containing validating messages 
about their decision for an abortion and contact information for accurate sources 
of reproductive health information, and the opportunity to discuss their 
experiences in a group setting (19). The messaging conveyed to the women 
framed abortion as the “end result of caring and moral women making hard 
choices” (19). All participants agreed that the intervention was useful, especially 
the emphasis on how “other women go through this, too” and the positive framing 
of abortion decisions (19). Most women felt that they could be more resilient to 
the negative attitudes and judgments from others after the intervention (19). We 
as health providers need to carry over these lessons learned to create 
environments where patients feel comfortable disclosing without judgment.  
A Focus on Comprehensive Contraceptive Care 
Once providers establish a safe environment for women to disclose their 
abortions, we can then focus on more important issues, such as why the 
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unplanned pregnancy occurred in the first place and what can be done to prevent 
another in the future. Ultimately the goal should be about how to find the 
appropriate method of contraception to shift the focus to prevention of 
unintended pregnancy. Diabetics need to maintain a medication regimen to keep 
their glycosylated hemoglobin at goal to prevent a complication like diabetic 
ketoacidosis, and similarly, women need to find the best contraceptive regimen to 
prevent an unintended pregnancy and abortion.  
Sixty percent of women with unintended pregnancy who undergo abortion 
used contraception in the month they became pregnant, but the majority of them 
used it inconsistently or incorrectly (3). This presents a golden opportunity for 
contraceptive care providers to intervene. If we want to curb the unintended 
pregnancy epidemic, the focus should shift to encouraging use of the most 
effective methods of reversible birth control that are “forgettable”, namely the 
intrauterine device (IUD) or subdermal implant, collectively called long-acting 
reversible contraception (LARC). LARC eliminates the need to remember to do 
anything, such as take a daily pill, change a weekly transdermal patch, or change 
a monthly vaginal ring. In a prospective study, the pill, patch, and ring had 
contraceptive failure rates that were twenty times higher than with LARC, and 
women younger than 21 years had double the failure rate with the pill, patch, and 
ring compared to women over 21 years (20). Other retrospective studies show 
similar findings of LARC effectiveness compared to other reversible 
contraception, with the following failure rates: 9% for oral contraceptives, 0.001% 
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for subdermal implant, 0.14% for levonorgestrel IUD, 0.7% for copper IUD (21-
22).  
Despite the fact that LARC methods are the most effective, women in the 
United States more commonly use less effective methods of birth control, such 
as oral contraceptives. If we as providers can reframe the way we counsel our 
patients by presenting LARC methods as the most effective at preventing 
pregnancy, we will start to see improvement in unintended pregnancy, abortion, 
and repeat abortion rates. The Contraceptive CHOICE project in St. Louis 
showed that contraceptive counseling that included information on all reversible 
methods with emphasis on the superior effectiveness of LARC along with the 
provision of contraception at no cost had a positive impact on reducing the 
abortion rate among study participants compared to the rest of the region and 
nation (23).  
LARC methods can save expenditures in our health care system. 
Annually, deliveries from unintended pregnancy alone cost the United States 
about $4.6 billion dollars (24). If only 10% of women on non-LARC methods of 
contraception or no contraception switched to LARC, it would save the United 
States $436 million dollars per year (24). This is an underestimate of the real cost 
savings because only the costs related to deliveries from unintended pregnancy 
are considered in this study, and not the cost savings from averting the need for 
prenatal care or other social and health services related to dealing with 
unintended pregnancy (24).  
  
 
39 
 While the advantages of LARC methods are numerous, its provision in the 
United States is low, especially in the post-abortion setting. About 60% of 
abortion centers provide only 6-15 minutes of contraceptive counseling and most 
commonly provide oral contraceptives, vaginal ring, or progesterone injection 
instead of more effective LARC methods (18). Only 32% of centers surveyed 
provide the intrauterine device or subdermal implant immediately postabortally, 
with comprehensive family planning centers being most likely to do so (18). Even 
though the disconnect in care exists between contraception and abortion care 
that may exacerbate the underutilization of LARC methods, the messaging 
around contraception needs to change at all levels—from a contraceptive care 
provider who does not provide abortions to abortion providers who do not spend 
enough time on contraceptive counseling.  
 
Limitations 
Our study is limited by its relatively small sample size, which we set as a 
convenience sample. However, we were still able to gather some interesting and 
robust results. There may also be an element of selection bias, since the women 
who chose to participate may differ from those who did not participate. Another 
limitation relates to the number of surveys that contained missing data. By 
excluding those surveys from our study, the results may not be representative.   
The results may not be generalizable to other geographic and health care 
settings. Study subjects were recruited from a setting that predominantly serves 
women of low socioeconomic status and minority demographics in the Northeast, 
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which has less restrictive abortion laws compared to other regions, such as the 
South or Midwest. Although abortion stigma is real and tangible in this region, it 
may be of a lesser degree compared to other parts of the country and could 
affect disclosure rates.    
 
Future Directions 
 We envisioned this study as a pilot, with the expectation that we would 
improve upon the survey and expand it to a wider variety of women across the 
United States. We hope to collaborate with other centers of abortion care in 
different regions, including areas where abortion may be more stigmatized and 
marginalized.  
 
Conclusions 
  Almost half of women did not disclose their abortion to their contraceptive 
care provider. The most common reasons for nondisclosure of the abortion were 
“I don’t want them to know I’m having an abortion” (44%), followed by “I’m 
changing providers” (20%). The common reasons why these women do not 
disclose are due to underlying abortion stigma and their fear of judgment and 
negative treatment from providers. Women were 72% less likely to disclose their 
abortion to an obstetrical/gynecological (OB/GYN) provider outside of the 
Planned Parenthood system (adjusted OR 0.28, 95% CI 0.10-0.75) and 90% less 
likely to disclose to a non-OB/GYN provider (adjusted OR 0.10, 95% CI 0.02-
0.42), compared to a Planned Parenthood contraceptive care provider. The 
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association of contraceptive care provider characteristics with disclosure, rather 
than more internal characteristics of the woman herself, demonstrates the 
pervasive nature of abortion stigma. The political nature and stigma surrounding 
abortion have isolated it from the rest of women’s health care to the point that a 
gap exists between the preventative care of contraception and abortion care, 
which is the treatment for failed prevention. Nondisclosure of abortion can lead to 
potential health complications or the continuation of suboptimal contraceptive 
regimens. Contraceptive care providers of any type are in a unique position not 
only to continue destigmatizing abortion, but also to encourage the use of the 
most effective reversible methods of contraception, including the intrauterine 
device and subdermal implant. In doing so we may curb the unintended 
pregnancy epidemic in the United States.  
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Appendix: Survey Instrument 
 
Pregnancy Conversations 
 
 
We are interested to know what women have talked about with their 
contraceptive providers before they come for an abortion.  
 
Thank you for doing this short, ANONYMOUS survey. We are grateful for 
your honest and careful answers. Filling out this survey is completely 
voluntary and confidential. Your care today will not be affected by your 
decision to do this survey. Your name or other identifying information will 
NOT be recorded. Feel free to skip any questions you do not wish to 
answer. If you have any concerns from doing the survey, please ask to 
speak with the research coordinator or call the phone number below.   
 
Please do NOT fill out this survey if: 
- You are not presenting for abortion services 
- You are currently a prisoner 
- You are currently a ward of the state, that is you are younger than 
eighteen and currently cared for by the Department of Children and 
Families  
 
Please return this packet to the PURPLE container marked “Pregnancy 
Conversations SURVEYS” at the front desk.  
 
If you want to keep our contact information, please keep this first page but 
return the rest of the packet. 
 
 
Thank you!   
 
Nancy L. Stanwood, MD, MPH, (203) 737-4665  
Clair Kaplan, MSN/APRN, MHS, (203) 752-2864 
Lisa An, Medical Student  
 
Clinic Location:  New Haven  Norwich  West Hartford   Stamford 
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Pregnancy Conversations 
Today’s Date: ______________    
A. How old are you? ______    
B. How far do you think you are in this pregnancy?  
1        First trimester (less than 12 weeks) 
2        Second trimester (more than 12 weeks) 
3        I do not know  
C. What were you doing to avoid pregnancy IN THE MONTH you got 
pregnant this time? Check as many birth control methods as you were 
using: 
    
 1. Condoms 
 2. The Pill 
 3. The 3 Month Shot, DepoProvera 
 4. The Patch, OrthoEvra 
 5. The Rhythm Method 
 6. Withdrawal, Pulling Out 
 7. Just Breast Feeding 
 8. The Vaginal Ring, NuvaRing 
 9. The IUD, Intrauterine Device, Mirena or ParaGard 
 10. Rod Implanted in Arm, Implanon or Nexplanon 
 11. Spermicide 
 12. Diaphragm 
 13.  Morning After Pill, Emergency Contraception, Plan B,    
 Next Choice, Ella  
 14. Vasectomy of your partner 
 15. Tubal ligation, Your tubes tied 
 16. Nothing, I thought I wouldn’t get pregnant 
 17. Nothing, I wanted to be pregnant 
 18. Nothing, I did not have a choice 
 19. Other:____________________________________ 
   46 
 
 
Version 2 as of July 11, 2012   
 
D.  If you were NOT using any method of pregnancy prevention when 
you got pregnant, when was the last time you did use something to 
prevent pregnancy?   
1 Less than 3 months ago 
2 Between 3 months and 6 months ago 
3 More than 6 months ago 
 
 
E.  What have you EVER used for pregnancy prevention in your whole life? 
CHECK ALL birth control methods that apply: 
    
 1. Condoms 
 2. The Pill 
 3. The 3 Month Shot, DepoProvera 
 4. The Patch, OrthoEvra 
 5. The Rhythm Method 
 6. Withdrawal, Pulling Out 
 7. Just Breast Feeding 
 8. The Vaginal Ring, NuvaRing 
 9. The IUD, Intrauterine Device, Mirena or ParaGard 
 10. Rod Implanted in Arm, Implanon or Nexplanon 
 11. Spermicide 
 12. Diaphragm 
 13. Morning After Pill, Emergency Contraception, Plan B,       
    Next Choice, Ella  
 14. Vasectomy of your partner 
 15. Tubal ligation, Your tubes tied 
 16. Nothing, I thought I wouldn’t get pregnant 
 17. Nothing, I wanted to be pregnant 
 18. Nothing, I did not have a choice 
 19. Other:____________________________________ 
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F.  In the past two years, did you have an office visit with a health care 
provider to talk about preventing pregnancy or about using birth control? 
 
1 Yes 
 
 
2 No  
 
 
 
G.  What kind of office was this provider in?  
1 Planned Parenthood 
2 Obstetric/Gynecology (OB/GYN) Office 
3 Private Medical Office 
5 Community Health Center 
6 Pediatric Office 
7 Other: ___________________________ 
 
 
 
H. What kind of provider did you see for this birth control care?  
            1 Obstetrical/Gynecological (OB/GYN) Provider 
            2 General Medical Provider 
            3 Pediatric Provider 
            4 Not sure 
            5 Other:___________________________ 
 
I. How long have you been getting care with this provider?  
1 Less than 6 months 
2 6 to 12 months 
3 1 to 2 years 
4 More than 2 years 
Please continue to the next question 
Thank you! You may stop the survey and return 
it to the PURPLE container marked “Pregnancy 
Conversations SURVEYS” at the front desk. 
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J.  Does this provider know that you are Pregnant? 
1  Yes           
2 No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M.  Does this provider know that you are having the Abortion? 
1 Yes, and they referred me to an abortion provider   
2 Yes, but they did NOT refer me to an abortion provider  
3 N
SKIP to 
Question P  
on the next 
page 
 
N. If NO, do you think you will tell them about your Abortion? 
1    Yes 
2    No 
3    No, but I will tell them I had a miscarriage 
4      Not sure 
 
O.  If you think you will NOT tell them about your Abortion, Please 
CHECK ALL of the reasons you don’t want to tell them: 
 
1    I’m embarrassed I got pregnant 
2    I don’t want them to know I’m having an abortion 
3    I’m afraid they will be disappointed in me 
4      I’m afraid they will judge me 
5    I’m afraid other people in my life may find out about the  
           abortion from their office  
6    They do not provide abortions 
7       I’m afraid my parents will find out 
8    Other reason:_________________________________ 
 
SKIP to Question M below 
K.  If NO, do you think you will tell them about the Pregnancy? 
1 Yes 
2 No 
3 Not sure 
 
L.  If you think you will NOT tell them about your Pregnancy, 
Please CHECK ALL of the reasons you don’t want to tell them: 
 
1 I’m embarrassed I got pregnant 
2 I don’t want them to know I’m having an abortion 
3 I’m afraid they will be disappointed in me 
4 I’m afraid they will judge me 
5 I’m afraid other people in my life may find out about the  
           pregnancy from their office  
6 They do not provide abortions 
7  I’m afraid my parents will find out 
8 Other 
reason:____________________________________ 
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P.  How would you describe your ethnic background?  
1 Hispanic or Latina 
2 Not Hispanic or Latina 
 
Q.  How would you describe you racial background? 
1 African-American or Black 
2 Caucasian or White  
3 Asian or Pacific Islander  
4 Native American  
5 Other: _________________________ 
 
R.  What is the highest grade you have finished? 
1 7
th grade 
2 8
th grade 
3 9
th grade 
4 10
th grade 
5 11
th grade 
6 12
th grade 
7 I got my GED 
8 I am in college now 
9 I have an associate’s degree 
10 I have a bachelor’s degree 
11 I have a graduate degree 
 
 
S. What type of health insurance are you using to cover your abortion 
today? 
1 Private Insurance: _________________________ 
2 Medicaid 
3 None, I’m paying for it myself. 
 
 
T.  What is your take-home household income in a year?   
1 Less than $10,000 
2 Between $10,000 and $20,000 
3 Between $20,000 and $30,000 
4 Between $30,000 and $40,000 
5 More than $40,000 per year 
6 Not sure 
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U. What number pregnancy is this for you, including all births, 
miscarriages, and abortions? 
1 1
st   
2 2
nd   
3 3
rd   
4 4
th  
5 5
th 
6 6
th  or more  
 
V.  How many live births have you had? 
1 None 
2 1  
3 2  
4 3  
5 4 
6 5 or more  
 
W. How many abortions (surgical or medication/pill) have you had before 
today? 
1 None  
2 One 
3 Two 
4 Three or more 
 
X. Are you planning on having a surgical or medication (pill) abortion 
today? 
 1  Surgical Abortion 
 2
 Medication (pill) Abortion 
 3 I don’t know 
 
Thank you! 
Please return this survey to the 
PURPLE container marked 
“Pregnancy Conversations 
SURVEYS” at the front desk. 
 
